Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

Emmanuel S. Onaivi, Hiroki Ishiguro, Jian Ping Gong, Sejal Patel, Alex Perchuk, Paul A. Meozzi, Lester Myers, Zoila Mora, Patricia Tagliaferro, Eileen Gardner, Alicia Brusco, Babatunde E. Akinshola, Qing Rong Liu, Bruce Hope, Shinya Iwasaki, Tadao Arinami, Lindsey Teasenfitz, George R. Uhl

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Two well-characterized cannabinoid receptors (CBrs), CB1 and CB2, mediate the effects of cannabinoids and marijuana use, with functional evidence for other CBrs. CBl receptors are expressed primarily in brain and peripheral tissues. For over a decade several laboratories were unable to detect CB2 receptors in brain and were known to be intensely expressed in peripheral and immune tissues and have traditionally been referred to as peripheral CB2 CBrs. We have reported the discovery and functional presence of CB2 cannabinoid receptors in mammalian brain that may be involved in depression and drug abuse and this was supported by reports of identification of neuronal CB2 receptors that are involved in emesis. We used ET-PCM, immunoblotting, hippocampal cultures, inununohistocfaemistry, transmission electron microscopy, and stereotaxic techniques with behavioral assays to determine the functional expression of CB2 CBrs in rat brain and mice brain exposed to chronic mild stress (CMS) or those treated with abused drugs. RT-PCR analyses supported the expression of brain CB2 receptor transcripts at levels much lower than those of CB1 receptors. In situ hybridization revealed CB2 mRNA in cerebellar neurons of wild-type but not of CB2 knockout mice. Abundant CB2 receptor immunoreactivity (iCB2) in neuronal and glial processes was detected in brain and CB2 expression was defected in neuron-specific enolase (NSE) positive hippocampal cell cultures. The effect of direct CB2 antisense oligonucleotide injection into the brain and treatment with JWH015 in motor function and plus-maze tests also demonstrated the functional presence of CB2 cannabinoid receptors in the central nervous system (CNS). Thus, contrary to the prevailing view that CB2 CBrs are restricted to peripheral tissues and predominantly in immune cells, we demonstrated that CB2 CBrs and their gene transcripts are widely distributed in the brain. This multifocal expression of CB2 immunoreactivity in brain suggests that CB2 receptors may play broader roles in the brain than previously anticipated and may be exploited as new targets in the treatment of depression and substance abuse.

Original languageEnglish (US)
Title of host publicationAnnals of the New York Academy of Sciences
Pages514-536
Number of pages23
Volume1074
DOIs
StatePublished - Aug 2006
Externally publishedYes

Publication series

NameAnnals of the New York Academy of Sciences
Volume1074
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Cannabinoid Receptor CB2
Brain
Cannabinoid Receptor CB1
Tissue
Substance-Related Disorders
Stereotaxic Techniques
Depression
Cannabinoid Receptors
Cannabinoids
Phosphopyruvate Hydratase
Antisense Oligonucleotides
Pulse code modulation
Cannabis
Transmission Electron Microscopy
Neurology
Immunoblotting
Knockout Mice
Neuroglia
Cell culture
Vomiting

Keywords

  • Brain
  • CB2 blocking peptide
  • CB2 cannabinoid receptor
  • CB2 electron micrograph
  • CB2 knockout mice
  • CB2 polyclonal antibody
  • Hippocampal cultures
  • Immunohistochemistry
  • In situ hybridization
  • mRNA
  • RT-PCR

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Onaivi, E. S., Ishiguro, H., Gong, J. P., Patel, S., Perchuk, A., Meozzi, P. A., ... Uhl, G. R. (2006). Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. In Annals of the New York Academy of Sciences (Vol. 1074, pp. 514-536). (Annals of the New York Academy of Sciences; Vol. 1074). https://doi.org/10.1196/annals.1369.052

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. / Onaivi, Emmanuel S.; Ishiguro, Hiroki; Gong, Jian Ping; Patel, Sejal; Perchuk, Alex; Meozzi, Paul A.; Myers, Lester; Mora, Zoila; Tagliaferro, Patricia; Gardner, Eileen; Brusco, Alicia; Akinshola, Babatunde E.; Liu, Qing Rong; Hope, Bruce; Iwasaki, Shinya; Arinami, Tadao; Teasenfitz, Lindsey; Uhl, George R.

Annals of the New York Academy of Sciences. Vol. 1074 2006. p. 514-536 (Annals of the New York Academy of Sciences; Vol. 1074).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Onaivi, ES, Ishiguro, H, Gong, JP, Patel, S, Perchuk, A, Meozzi, PA, Myers, L, Mora, Z, Tagliaferro, P, Gardner, E, Brusco, A, Akinshola, BE, Liu, QR, Hope, B, Iwasaki, S, Arinami, T, Teasenfitz, L & Uhl, GR 2006, Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. in Annals of the New York Academy of Sciences. vol. 1074, Annals of the New York Academy of Sciences, vol. 1074, pp. 514-536. https://doi.org/10.1196/annals.1369.052
Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. In Annals of the New York Academy of Sciences. Vol. 1074. 2006. p. 514-536. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1369.052
Onaivi, Emmanuel S. ; Ishiguro, Hiroki ; Gong, Jian Ping ; Patel, Sejal ; Perchuk, Alex ; Meozzi, Paul A. ; Myers, Lester ; Mora, Zoila ; Tagliaferro, Patricia ; Gardner, Eileen ; Brusco, Alicia ; Akinshola, Babatunde E. ; Liu, Qing Rong ; Hope, Bruce ; Iwasaki, Shinya ; Arinami, Tadao ; Teasenfitz, Lindsey ; Uhl, George R. / Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Annals of the New York Academy of Sciences. Vol. 1074 2006. pp. 514-536 (Annals of the New York Academy of Sciences).
@inproceedings{f8917e75beda4d90bf489e0086a1a586,
title = "Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain",
abstract = "Two well-characterized cannabinoid receptors (CBrs), CB1 and CB2, mediate the effects of cannabinoids and marijuana use, with functional evidence for other CBrs. CBl receptors are expressed primarily in brain and peripheral tissues. For over a decade several laboratories were unable to detect CB2 receptors in brain and were known to be intensely expressed in peripheral and immune tissues and have traditionally been referred to as peripheral CB2 CBrs. We have reported the discovery and functional presence of CB2 cannabinoid receptors in mammalian brain that may be involved in depression and drug abuse and this was supported by reports of identification of neuronal CB2 receptors that are involved in emesis. We used ET-PCM, immunoblotting, hippocampal cultures, inununohistocfaemistry, transmission electron microscopy, and stereotaxic techniques with behavioral assays to determine the functional expression of CB2 CBrs in rat brain and mice brain exposed to chronic mild stress (CMS) or those treated with abused drugs. RT-PCR analyses supported the expression of brain CB2 receptor transcripts at levels much lower than those of CB1 receptors. In situ hybridization revealed CB2 mRNA in cerebellar neurons of wild-type but not of CB2 knockout mice. Abundant CB2 receptor immunoreactivity (iCB2) in neuronal and glial processes was detected in brain and CB2 expression was defected in neuron-specific enolase (NSE) positive hippocampal cell cultures. The effect of direct CB2 antisense oligonucleotide injection into the brain and treatment with JWH015 in motor function and plus-maze tests also demonstrated the functional presence of CB2 cannabinoid receptors in the central nervous system (CNS). Thus, contrary to the prevailing view that CB2 CBrs are restricted to peripheral tissues and predominantly in immune cells, we demonstrated that CB2 CBrs and their gene transcripts are widely distributed in the brain. This multifocal expression of CB2 immunoreactivity in brain suggests that CB2 receptors may play broader roles in the brain than previously anticipated and may be exploited as new targets in the treatment of depression and substance abuse.",
keywords = "Brain, CB2 blocking peptide, CB2 cannabinoid receptor, CB2 electron micrograph, CB2 knockout mice, CB2 polyclonal antibody, Hippocampal cultures, Immunohistochemistry, In situ hybridization, mRNA, RT-PCR",
author = "Onaivi, {Emmanuel S.} and Hiroki Ishiguro and Gong, {Jian Ping} and Sejal Patel and Alex Perchuk and Meozzi, {Paul A.} and Lester Myers and Zoila Mora and Patricia Tagliaferro and Eileen Gardner and Alicia Brusco and Akinshola, {Babatunde E.} and Liu, {Qing Rong} and Bruce Hope and Shinya Iwasaki and Tadao Arinami and Lindsey Teasenfitz and Uhl, {George R.}",
year = "2006",
month = "8",
doi = "10.1196/annals.1369.052",
language = "English (US)",
isbn = "1573316296",
volume = "1074",
series = "Annals of the New York Academy of Sciences",
pages = "514--536",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

AU - Onaivi, Emmanuel S.

AU - Ishiguro, Hiroki

AU - Gong, Jian Ping

AU - Patel, Sejal

AU - Perchuk, Alex

AU - Meozzi, Paul A.

AU - Myers, Lester

AU - Mora, Zoila

AU - Tagliaferro, Patricia

AU - Gardner, Eileen

AU - Brusco, Alicia

AU - Akinshola, Babatunde E.

AU - Liu, Qing Rong

AU - Hope, Bruce

AU - Iwasaki, Shinya

AU - Arinami, Tadao

AU - Teasenfitz, Lindsey

AU - Uhl, George R.

PY - 2006/8

Y1 - 2006/8

N2 - Two well-characterized cannabinoid receptors (CBrs), CB1 and CB2, mediate the effects of cannabinoids and marijuana use, with functional evidence for other CBrs. CBl receptors are expressed primarily in brain and peripheral tissues. For over a decade several laboratories were unable to detect CB2 receptors in brain and were known to be intensely expressed in peripheral and immune tissues and have traditionally been referred to as peripheral CB2 CBrs. We have reported the discovery and functional presence of CB2 cannabinoid receptors in mammalian brain that may be involved in depression and drug abuse and this was supported by reports of identification of neuronal CB2 receptors that are involved in emesis. We used ET-PCM, immunoblotting, hippocampal cultures, inununohistocfaemistry, transmission electron microscopy, and stereotaxic techniques with behavioral assays to determine the functional expression of CB2 CBrs in rat brain and mice brain exposed to chronic mild stress (CMS) or those treated with abused drugs. RT-PCR analyses supported the expression of brain CB2 receptor transcripts at levels much lower than those of CB1 receptors. In situ hybridization revealed CB2 mRNA in cerebellar neurons of wild-type but not of CB2 knockout mice. Abundant CB2 receptor immunoreactivity (iCB2) in neuronal and glial processes was detected in brain and CB2 expression was defected in neuron-specific enolase (NSE) positive hippocampal cell cultures. The effect of direct CB2 antisense oligonucleotide injection into the brain and treatment with JWH015 in motor function and plus-maze tests also demonstrated the functional presence of CB2 cannabinoid receptors in the central nervous system (CNS). Thus, contrary to the prevailing view that CB2 CBrs are restricted to peripheral tissues and predominantly in immune cells, we demonstrated that CB2 CBrs and their gene transcripts are widely distributed in the brain. This multifocal expression of CB2 immunoreactivity in brain suggests that CB2 receptors may play broader roles in the brain than previously anticipated and may be exploited as new targets in the treatment of depression and substance abuse.

AB - Two well-characterized cannabinoid receptors (CBrs), CB1 and CB2, mediate the effects of cannabinoids and marijuana use, with functional evidence for other CBrs. CBl receptors are expressed primarily in brain and peripheral tissues. For over a decade several laboratories were unable to detect CB2 receptors in brain and were known to be intensely expressed in peripheral and immune tissues and have traditionally been referred to as peripheral CB2 CBrs. We have reported the discovery and functional presence of CB2 cannabinoid receptors in mammalian brain that may be involved in depression and drug abuse and this was supported by reports of identification of neuronal CB2 receptors that are involved in emesis. We used ET-PCM, immunoblotting, hippocampal cultures, inununohistocfaemistry, transmission electron microscopy, and stereotaxic techniques with behavioral assays to determine the functional expression of CB2 CBrs in rat brain and mice brain exposed to chronic mild stress (CMS) or those treated with abused drugs. RT-PCR analyses supported the expression of brain CB2 receptor transcripts at levels much lower than those of CB1 receptors. In situ hybridization revealed CB2 mRNA in cerebellar neurons of wild-type but not of CB2 knockout mice. Abundant CB2 receptor immunoreactivity (iCB2) in neuronal and glial processes was detected in brain and CB2 expression was defected in neuron-specific enolase (NSE) positive hippocampal cell cultures. The effect of direct CB2 antisense oligonucleotide injection into the brain and treatment with JWH015 in motor function and plus-maze tests also demonstrated the functional presence of CB2 cannabinoid receptors in the central nervous system (CNS). Thus, contrary to the prevailing view that CB2 CBrs are restricted to peripheral tissues and predominantly in immune cells, we demonstrated that CB2 CBrs and their gene transcripts are widely distributed in the brain. This multifocal expression of CB2 immunoreactivity in brain suggests that CB2 receptors may play broader roles in the brain than previously anticipated and may be exploited as new targets in the treatment of depression and substance abuse.

KW - Brain

KW - CB2 blocking peptide

KW - CB2 cannabinoid receptor

KW - CB2 electron micrograph

KW - CB2 knockout mice

KW - CB2 polyclonal antibody

KW - Hippocampal cultures

KW - Immunohistochemistry

KW - In situ hybridization

KW - mRNA

KW - RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=33749544716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749544716&partnerID=8YFLogxK

U2 - 10.1196/annals.1369.052

DO - 10.1196/annals.1369.052

M3 - Conference contribution

SN - 1573316296

SN - 9781573316293

VL - 1074

T3 - Annals of the New York Academy of Sciences

SP - 514

EP - 536

BT - Annals of the New York Academy of Sciences

ER -